Breast Clinical Trials

Breast Clinical Trials

TRIALS CURRENTLY OPEN

USOR #17188

A Randomized, Double-Blind, Phase III Study of Pembrolizumab versus Placebo in Combination with Neoadjuvant Chemotherapy and Adjuvant Endocrine Therapy for the Treatment of High-Risk Early-Stage Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast Cancer (MK3475-KN756)

Also See STAR TrialsUSOR #14059, #19054

WordPress Appliance - Powered by TurnKey Linux